20B Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioMark Diagnostics Inc

Watchlist Manager

Watchlist

Price: 0.286 EUR -6.54% Market Closed

Market Cap: €26m

	BioMark Diagnostics Inc F:20B	CA
J	Jetema Co Ltd KOSDAQ:216080	KR
S	Sanu Gold Corp OTC:SNGCF	CA
	Iren SpA OTC:IRDEF	IT
	Bumi Citra Permai Tbk PT IDX:BCIP	ID
C	Ciscom Corp OTC:CISCF	CA

Profitability Summary

BioMark Diagnostics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-6 783%

Negative 3Y Average Operating Margin

-2 007%

Declining Operating Margin

-1 028% > -6 783%

Negative Net Margin

-5 128%

Negative 3Y Average Net Margin

-1 677%

Declining Net Margin

-962% > -5 128%

Negative Free Cash Flow Margin

-3 834%

Negative 3Y Average Free Cash Flow Margin

-1 235%

Declining Free Cash Flow Margin

-374% > -3 834%

Negative ROE

-150%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-389%

ROIC is Increasing

-335% > -240%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.